Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
- K. Do, A. H. Trabesinger, +6 authors M. Cuénod
- Psychology, Medicine
- The European journal of neuroscience
- 1 October 2000
Schizophrenia is a major psychiatric disease, which affects the centre of the personality, with severe problems of perception, cognition as well as affective and social behaviour. In cerebrospinal… Expand
Perineuronal nets protect fast-spiking interneurons against oxidative stress
- Jan-Harry cabungcal, P. Steullet, +4 authors K. Do
- Biology, Medicine
- Proceedings of the National Academy of Sciences
- 13 May 2013
A hallmark of schizophrenia pathophysiology is the dysfunction of cortical inhibitory GABA neurons expressing parvalbumin, which are essential for coordinating neuronal synchrony during various… Expand
TORC1 is a calcium- and cAMP-sensitive coincidence detector involved in hippocampal long-term synaptic plasticity
- Krisztián A. Kovács, P. Steullet, +4 authors J. Cardinaux
- Biology, Medicine
- Proceedings of the National Academy of Sciences
- 13 March 2007
A key feature of memory processes is to link different input signals by association and to preserve this coupling at the level of synaptic connections. Late-phase long-term potentiation (L-LTP), a… Expand
Redox dysregulation, neurodevelopment, and schizophrenia
- K. Do, J. Cabungcal, A. Frank, P. Steullet, M. Cuénod
- Psychology, Medicine
- Current Opinion in Neurobiology
- 1 April 2009
In schizophrenia, a developmental redox dysregulation constitutes one 'hub' on which converge genetic impairments of glutathione synthesis and environmental vulnerability factors generating oxidative… Expand
Early-Life Insults Impair Parvalbumin Interneurons via Oxidative Stress: Reversal by N-Acetylcysteine
- Jan-Harry cabungcal, P. Steullet, R. Kraftsik, M. Cuénod, K. Do
- Biology, Medicine
- Biological Psychiatry
- 15 March 2013
BACKGROUND
A hallmark of the pathophysiology of schizophrenia is a dysfunction of parvalbumin-expressing fast-spiking interneurons, which are essential for the coordination of neuronal synchrony… Expand
Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients
- Suzie Lavoie, M. Murray, +14 authors K. Do
- Psychology, Medicine
- Neuropsychopharmacology
- 1 August 2008
In schizophrenia patients, glutathione dysregulation at the gene, protein and functional levels, leads to N-methyl-D-aspartate (NMDA) receptor hypofunction. These patients also exhibit deficits in… Expand
Juvenile Antioxidant Treatment Prevents Adult Deficits in a Developmental Model of Schizophrenia
- Jan-Harry Cabungcal, D. Counotte, +11 authors P. O'Donnell
- Psychology, Medicine
- Neuron
- 3 September 2014
Abnormal development can lead to deficits in adult brain function, a trajectory likely underlying adolescent-onset psychiatric conditions such as schizophrenia. Developmental manipulations yielding… Expand
Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate
- D. Piani, K. Frei, K. Do, M. Cuénod, A. Fontana
- Biology, Medicine
- Neuroscience Letters
- 9 December 1991
Supernatants (SN) of brain macrophages in culture induce death of cerebellar granule cells in vitro, while those of astrocytes and endothelial cells do not. This toxicity can be prevented by… Expand
Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence
- R. Gysin, R. Kraftsik, +11 authors K. Do
- Biology, Medicine
- Proceedings of the National Academy of Sciences
- 16 October 2007
Schizophrenia is a complex multifactorial brain disorder with a genetic component. Convergent evidence has implicated oxidative stress and glutathione (GSH) deficits in the pathogenesis of this… Expand
Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia
- P. Steullet, H. Neijt, M. Cuénod, K. Do
- Chemistry, Medicine
- Neuroscience
- 31 December 2006
Increasing evidence suggests that the metabolism of glutathione, an endogenous redox regulator, is abnormal in schizophrenia. Patients show a deficit in glutathione levels in the cerebrospinal fluid… Expand